Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Gamida Cell Ltd GMDAQ

Healthcare Biotechnology
Gamida Cell Ltd is an Israel-based clinical-stage biopharmaceutical company. The Company develops cell therapies that are designed to cure cancer and rare, serious hematologic diseases. The Company is leveraging its nicotinamide (NAM)-based cell expansion technology toto expand multiple cell types including stem cells and natural killer (NK) cells while maintaining their original phenotype and... see more

Recent & Breaking News (PINL:GMDAQ)

Gamida Cell Announces Updated Data from Phase 1 Study of GDA-201 to be Presented at the Annual Meeting of the European Society for Blood and Marrow Transplantation

Business Wire March 2, 2020

Gamida Cell Reports Full Year 2019 Financial Results and Provides Company Update

Business Wire February 25, 2020

Gamida Cell Announces the Date of Its Full Year 2019 Financial Results and Webcast

Business Wire February 19, 2020

Gamida Cell Announces 2020 Goals and Provides Company Update

Business Wire January 13, 2020

Gamida Cell Announces Completion of Patient Enrollment in Ongoing Phase 3 Clinical Study of Omidubicel

Business Wire January 2, 2020

Gamida Cell Announces Results from Phase 1 Study of GDA-201 and New Mechanism of Action Data at ASH 2019 Annual Meeting

Business Wire December 9, 2019

Gamida Cell to Present at the 31st Annual Piper Jaffray Healthcare Conference

Business Wire November 21, 2019

Gamida Cell Reports Third Quarter 2019 Financial Results and Provides Company Update

Business Wire November 13, 2019

Gamida Cell Announces Data to be Presented at ASH 2019 Annual Meeting

Business Wire November 6, 2019

Gamida Cell Announces the Date of Its Third Quarter 2019 Financial Results and Webcast

Business Wire November 5, 2019

Gamida Cell and the CIBMTR Announce Collaboration to Advance Research for Life-Saving Cellular Therapy

Business Wire September 11, 2019

Gamida Cell Reports Second Quarter 2019 Financial Results and Provides Company Update

Business Wire August 6, 2019

Gamida Cell Announces the Date of Its Second Quarter 2019 Financial Results and Webcast

Business Wire July 23, 2019

Gamida Cell Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

Business Wire July 8, 2019

Gamida Cell Announces Pricing of $35 Million Public Offering of Ordinary Shares

Business Wire June 26, 2019

ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL ANNOUNCES LAUNCH OF PROPOSED PUBLIC OFFERING OF ORDINARY SHARES

GlobeNewswire June 25, 2019

Gamida Cell Announces Launch of Proposed Public Offering of Ordinary Shares

Business Wire June 24, 2019

Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel

Business Wire June 19, 2019

Gamida Cell Bolsters Management Team with Appointment of Tracey Lodie, Ph.D., as Chief Scientific Officer

Business Wire June 5, 2019

Gamida Cell Announces Data for Omidubicel Presented at the International Society for Cellular and Gene Therapy 2019 Annual Meeting

Business Wire May 31, 2019